In conclusion, we provide a unique characterization of postprandial bile acid and FGF19 levels in CTX patients that are associated with changes in postprandial glucose and insulin profiles as well as postprandial GLP-1 responses. This evidence concerns the gene FGF19 and cerebrotendinous xanthomatosis.